Indraprastha Medical Financials
| INDRAMEDCO | 466.50 1.25 0.27% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 1.9 B | 1.8 B |
|
|
Indraprastha | Select Account or Indicator |
Understanding current and past Indraprastha Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Indraprastha Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Indraprastha Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Indraprastha Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Indraprastha Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Indraprastha Medical's management manipulating its earnings.
Indraprastha Medical Stock Summary
Indraprastha Medical competes with Kingfa Science, Rico Auto, GACM Technologies, COSMO FIRST, and Delta Manufacturing. Indraprastha Medical is entity of India. It is traded as Stock on NSE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | India Stock View All |
| Exchange | National Stock Exchange of India |
| ISIN | INE681B01017 |
| Business Address | Sarita Vihar, New |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.apollohospitals.com/delhi/ |
| Phone | 91 11 2692 5858 |
You should never invest in Indraprastha Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Indraprastha Stock, because this is throwing your money away. Analyzing the key information contained in Indraprastha Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Indraprastha Medical Key Financial Ratios
There are many critical financial ratios that Indraprastha Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Indraprastha Medical reports annually and quarterly.| Revenue | 12.45 B | ||||
| Gross Profit | 7.76 B | ||||
| EBITDA | 2.1 B | ||||
| Net Income | 1.24 B | ||||
| Total Asset | 7.23 B |
Indraprastha Medical Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 4.3B | 4.6B | 5.6B | 7.2B | 8.3B | 4.7B | |
| Other Current Liab | 768.0M | 467.6M | 635M | 770.1M | 693.1M | 628.9M | |
| Net Debt | (171.0M) | (364.3M) | (497.8M) | (276.5M) | (248.9M) | (236.4M) | |
| Cash | 249.2M | 417.4M | 522.6M | 616M | 708.4M | 743.8M | |
| Net Receivables | 748.4M | 481.3M | 746.2M | 590.1M | 678.6M | 804.2M | |
| Inventory | 87.4M | 99.9M | 84.5M | 75.3M | 67.8M | 79.8M | |
| Other Current Assets | 303.2M | 333M | 138M | 153.1M | 137.8M | 130.9M | |
| Total Liab | 1.6B | 1.4B | 1.8B | 2.5B | 2.8B | 2.3B | |
| Total Current Assets | 1.4B | 1.6B | 2.2B | 3.1B | 3.5B | 3.7B | |
| Short Term Debt | 25.1M | (40.4M) | (44.6M) | 16.8M | 15.1M | 14.4M | |
| Accounts Payable | 366M | 370.4M | 522.9M | 773.5M | 889.5M | 501.3M | |
| Intangible Assets | 33.8M | 17.1M | 9.6M | 10.5M | 12.1M | 16.3M | |
| Retained Earnings | 1.4B | 2.0B | 2.6B | 3.6B | 4.1B | 4.3B | |
| Other Liab | 392.4M | 337.7M | 379.9M | 402.9M | 362.6M | 322.9M | |
| Net Tangible Assets | 2.4B | 2.7B | 2.7B | 3.2B | 3.7B | 2.6B | |
| Other Assets | 38.6M | 44.1M | 70.6M | 1.0 | 0.9 | 0.86 | |
| Net Invested Capital | 2.7B | 3.3B | 3.8B | 4.8B | 5.5B | 3.6B | |
| Net Working Capital | 255.2M | 639.3M | 934.5M | 1.4B | 1.6B | 1.7B |
Indraprastha Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 40K | 100K | 42.8M | 40.6M | 36.5M | 35.6M | |
| Total Revenue | 6.0B | 8.6B | 11.0B | 12.4B | 14.3B | 7.2B | |
| Gross Profit | 3.5B | 4.8B | 6.2B | 4.5B | 5.2B | 4.0B | |
| Operating Income | 76.6M | 851.3M | 1.1B | 1.6B | 1.8B | 1.9B | |
| Ebit | 76.3M | 824.8M | 1.2B | 1.7B | 2.0B | 2.1B | |
| Ebitda | 409.5M | 1.2B | 1.6B | 2.1B | 2.4B | 2.5B | |
| Cost Of Revenue | 2.5B | 3.8B | 4.7B | 7.9B | 9.1B | 9.5B | |
| Income Before Tax | 42.9M | 790.7M | 1.2B | 1.7B | 1.9B | 2.0B | |
| Net Income | 23.3M | 586.2M | 861.5M | 1.2B | 1.4B | 1.5B | |
| Income Tax Expense | 19.6M | 204.5M | 310.3M | 421.5M | 484.7M | 509.0M | |
| Tax Provision | 19.6M | 204.5M | 310.3M | 421.5M | 484.7M | 509.0M | |
| Interest Income | 33.4M | 34.1M | 42.8M | 168.9M | 194.2M | 203.9M | |
| Net Interest Income | (33.4M) | (34.1M) | (42.8M) | (40.6M) | (46.7M) | (49.0M) |
Indraprastha Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Indraprastha Medical. It measures of how well Indraprastha is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Indraprastha Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Indraprastha had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Indraprastha Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 33.3M | (12.5M) | 15.4M | 9.2M | 10.6M | 11.1M | |
| Change In Cash | 45.9M | 168.2M | 105.2M | 93.4M | 107.4M | 112.8M | |
| Free Cash Flow | 69.4M | 418.1M | 998.9M | 1.3B | 1.5B | 1.6B | |
| Depreciation | 333.2M | 349.4M | 392.7M | 400.8M | 460.9M | 300.3M | |
| Other Non Cash Items | (85.3M) | (162.6M) | (186.4M) | (193.5M) | (174.2M) | (182.9M) | |
| Dividends Paid | 2.5M | 2.6M | 228.4M | (275.4M) | (247.9M) | (235.5M) | |
| Capital Expenditures | 209.6M | 294.8M | 445.8M | 693.9M | 798.0M | 837.9M | |
| Net Income | 42.9M | 790.7M | 1.2B | 1.2B | 1.4B | 1.5B | |
| End Period Cash Flow | 249.2M | 417.4M | 522.6M | 616M | 708.4M | 743.8M | |
| Net Borrowings | (260M) | (228.5M) | (20.9M) | (25.1M) | (28.9M) | (30.3M) | |
| Change To Netincome | 37.3M | (56.4M) | (65.7M) | 41.9M | 37.7M | 39.6M | |
| Investments | (201.6M) | (241M) | (1.1B) | (1.6B) | (1.4B) | (1.4B) |
Indraprastha Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Indraprastha Medical's current stock value. Our valuation model uses many indicators to compare Indraprastha Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Indraprastha Medical competition to find correlations between indicators driving Indraprastha Medical's intrinsic value. More Info.Indraprastha Medical is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Indraprastha Medical is roughly 2.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Indraprastha Medical's earnings, one of the primary drivers of an investment's value.Indraprastha Medical Systematic Risk
Indraprastha Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Indraprastha Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Indraprastha Medical correlated with the market. If Beta is less than 0 Indraprastha Medical generally moves in the opposite direction as compared to the market. If Indraprastha Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Indraprastha Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Indraprastha Medical is generally in the same direction as the market. If Beta > 1 Indraprastha Medical moves generally in the same direction as, but more than the movement of the benchmark.
Indraprastha Medical Total Assets Over Time
Indraprastha Medical Thematic Clasifications
Indraprastha Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Indraprastha Medical February 8, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Indraprastha Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Indraprastha Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Indraprastha Medical based on widely used predictive technical indicators. In general, we focus on analyzing Indraprastha Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Indraprastha Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.61 | |||
| Information Ratio | 0.0191 | |||
| Maximum Drawdown | 16.94 | |||
| Value At Risk | (5.91) | |||
| Potential Upside | 5.57 |
Complementary Tools for Indraprastha Stock analysis
When running Indraprastha Medical's price analysis, check to measure Indraprastha Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indraprastha Medical is operating at the current time. Most of Indraprastha Medical's value examination focuses on studying past and present price action to predict the probability of Indraprastha Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indraprastha Medical's price. Additionally, you may evaluate how the addition of Indraprastha Medical to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |